BioWorld MedTech

July 18, 2019

Paragon Biosciences unveils Qlarity Imaging to advance Quantx system

Chicago-based Paragon Biosciences LLC has launched its seventh portfolio company, Qlarity Imaging LLC, which will focus on further developing Quantx, an FDA-cleared, computer-aided breast cancer diagnosis system. Read More

Endotronix enrolls first patient in CE mark trial for pulmonary artery pressure sensor

Casetabs secures $3M for surgical coordination tech

Industry seeks clarity in FDA's draft rule on radiological health regs

To treat or not to treat? Machine learning has answers

Regulatory front

Financings

Daily M&A

Appointments and advancements

Other news to note

Product regulatory actions for July 17, 2019

BioWorld MedTech's Orthopedics Extra

Today's news in brief

BioWorld

BioWorld briefs for May 20, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for May 19, 2026

WHO declares Ebola outbreak a public health emergency of international concern

BioWorld

The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...

Acid alpha-glucosidase molecular structure isolated on black

‘Detargeted’ targeted gene therapy improves activity in Pompe

BioWorld

A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...

Nxera Pharma prepares and tests new GPR17 antagonists

BioWorld Science

Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...